Zacks Investment Research
05 Aug 2026, 15:51 UTC · 12w ago
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
Impact · against what's priced in
FMS is seeing a divergence between strong operational profitability and weak top-line growth. While the 28% EPS increase and Care Delivery margin expansion are positive, the revenue miss and declining U.S. same-market treatment growth suggest fundamental headwinds in patient acquisition.
- FMS+0.30
No priced-in read yet
- In context
The 28% year-over-year increase in adjusted EPS and margin expansion in Care Delivery are strong positive catalysts, though they are tempered by a revenue miss and a 0.9% decline in U.S. same-market treatment growth.
Read from the article alone
Top 1 mover · tap to explore
